Cardiac Monitoring Devices Market Global Report 2026

The cardiac monitoring devices market size has grown strongly in recent years. It will grow from $25.91 billion in 2025 to $28.15 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases worldwide, growing aging population requiring cardiac care, rising adoption of cardiac monitoring devices in hospitals and clinics, expanding healthcare infrastructure development, and increasing demand for early diagnosis and preventive cardiac care.

The cardiac monitoring devices market size is expected to see strong growth in the next few years. It will grow to $38.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac monitoring solutions, growing adoption of wearable cardiac monitoring devices, rising healthcare digitization and remote patient monitoring services, expanding demand for personalized cardiac care solutions, and increasing focus on continuous cardiovascular disease management. Major trends in the forecast period include increasing adoption of remote cardiac monitoring solutions for continuous patient care, growing demand for portable and wearable cardiac monitoring devices, rising focus on early detection and management of cardiovascular diseases, expansion of home-based cardiac monitoring and decentralized healthcare services, and increasing integration of advanced sensor technologies in cardiac monitoring devices.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the cardiac monitoring devices market in the coming years. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attack, stroke, and hypertension. The prevalence of cardiovascular diseases is increasing due to unhealthy lifestyle habits such as poor diet, physical inactivity, smoking, and excessive alcohol consumption, along with rising obesity, diabetes, stress, and an aging population. Cardiac monitoring devices support the early detection, continuous monitoring, and timely clinical intervention of cardiovascular diseases by providing real-time cardiac data that improves diagnosis and treatment decisions. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, approximately one in six cardiovascular disease deaths occurred among adults younger than 65 years. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the cardiac monitoring devices market.

Major companies operating in the cardiac monitoring devices market are increasingly focusing on developing innovative products, such as wearable cardiac monitoring systems, to facilitate continuous cardiac rhythm monitoring, improve diagnostic accuracy, and enhance patient adherence. Wearable cardiac monitoring systems are compact medical devices designed to continuously record electrocardiogram (ECG) activity and wirelessly transmit cardiac data for clinical assessment, offering a more convenient and efficient alternative to conventional Holter monitors, which often require manual data retrieval and device return. For instance, in April 2026, RhythMedix, LLC, a US-based cardiac monitoring company, launched the RhythmStar SL cardiac monitor, a third-generation wearable cardiac monitoring device developed to enhance patient experience and clinical performance. The device incorporates a compact lead configuration, an IPX6-rated waterproof design, extended battery life, and built-in cellular connectivity that automatically transmits ECG data to the cloud without requiring patients to return the device for analysis. Additionally, when integrated with the company’s Augmented Arrhythmia Intelligence platform, the monitor combines advanced detection algorithms with a multi-layered review process to deliver accurate arrhythmia detection while supporting timely clinical decision-making.

In December 2024, SmartCardia SA, a Switzerland-based medtech company, acquired Cardiomedix for an undisclosed amount. Through this acquisition, SmartCardia aims to establish a fully integrated, end-to-end cardiac monitoring ecosystem in the United States by combining its FDA-cleared wearable ECG technology and cloud analytics with Cardiomedix’s accredited diagnostic testing services to strengthen its clinical service delivery capabilities. Cardiomedix Inc. is a US-based company that provides cardiac monitoring devices and remote monitoring services.

Major companies operating in the cardiac monitoring devices market are Abbott Laboratories, AliveCor Inc., Asahi Kasei Corporation, Baxter International Inc., BIOTRONIK SE & Co. KG, BPL Medical Technologies Private Limited, Boston Scientific Corporation, Edwards Lifesciences Corporation, Fukuda Denshi Co. Ltd., GE HealthCare Technologies Inc., iRhythm Technologies Inc., Koninklijke Philips N.V., LivaNova PLC, Masimo Corporation, Medtronic plc, MicroPort Scientific Corporation, Nihon Kohden Corporation, Omron Healthcare Inc., OSI Systems Inc., Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

North America was the dominant region in the cardiac monitoring devices market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the cardiac monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.